Company profile: Medyria
1.1 - Company Overview
Company description
- Provider of sensor-based medical devices for cardiovascular catheter navigation and sensing, based on proprietary Blood Flow Velocity Sensor technology. Products include TrackCath for minimally invasive endovascular and EVAR procedures with real-time catheter positioning and blood flow velocity data, and PyCath for real-time monitoring of key physiological parameters during interventional cardiology procedures.
Products and services
- TrackCath: A proprietary, sensor-based system for minimally invasive endovascular procedures that delivers real-time catheter positioning and blood-flow velocity data, engineered to be cost-effective and safe during EVAR
- PyCath: A sensor-based system for interventional cardiology that supplies real-time information on key physiological parameters during procedures, built to integrate intra-procedural sensing for enhanced clinician awareness
- EVAR: An endovascular procedure that treats aortic aneurysms by placing an expandable stent graft within the aorta, avoiding direct surgery on the aorta
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Medyria
Bittium
HQ: Finland
Website
- Description: Provider of reliable and secure communications and connectivity solutions using the latest technologies, including Tough Mobile 2 secure smartphone for tactical use; Tough Mobile 2 C combining device management and encryption for confidential data; Tough SDR software-defined radios; TAC WIN tactical wireless IP network; ESSOR HDRWF high data rate waveform; and Tactical VoIP for resilient battlefield voice and messaging.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bittium company profile →
Puzzle Medical
HQ: Canada
Website
- Description: Provider of minimally invasive long-term hemodynamic transcatheter pump solutions for advanced heart failure. Offers ModulHeart, a modular percutaneous heart pump supporting cardiac and renal function via multiple pumps anchored in parallel in the descending aorta, a portable controller with a long-life battery for autonomous operation, and a bedside monitoring station for cath lab programming and monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Puzzle Medical company profile →
Neuravi
HQ: Ireland
Website
- Description: Provider of neurointerventional medical products and services focused on acute ischemic stroke, leveraging an initial technology platform. Early-stage company led by a team experienced in endovascular device development and global commercialization, collaborating with international researchers and clinicians.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neuravi company profile →
Ionetix
HQ: United States
Website
- Description: Provider of end-to-end radiopharmaceutical solutions for cardiac PET imaging, including N-13 Ammonia for myocardial perfusion; the ION-12SC compact superconducting cyclotron for on/near-campus N-13 production; Cardiac PET consultative services (layout, regulatory, camera/software, training); and targeted alpha therapy using Actinium-225 and Astatine-211 to target cancer cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ionetix company profile →
Myogen
HQ: United States
Website
- Description: Provider of small molecule therapeutics for cardiovascular disorders, focused on the discovery, development and commercialization of treatments, combining advanced understanding of cardiovascular disease biology with clinical development expertise in cardiovascular therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Myogen company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Medyria
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Medyria
2.2 - Growth funds investing in similar companies to Medyria
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Medyria
4.2 - Public trading comparable groups for Medyria
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →